Citrate anticoagulation for continuous renal replacement therapy
- PMID: 39037609
- DOI: 10.1007/s00134-024-07531-3
Citrate anticoagulation for continuous renal replacement therapy
References
-
- Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, Wang P, Li L, Jing R, Zhao L, Sun S (2015) Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med 41(12):2098–2110. https://doi.org/10.1007/s00134-015-4099-0 - DOI - PubMed
-
- Zhang Z, Hongying N (2012) Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med 38(1):20–28. https://doi.org/10.1007/s00134-011-2438-3 - DOI - PubMed
-
- Jonckheer J, Spapen H, Malbrain MLNG, Oschima T, De Waele E (2020) Energy expenditure and caloric targets during continuous renal replacement therapy under regional citrate anticoagulation. A viewpoint. Clin Nutr 39(2):353–357. https://doi.org/10.1016/j.clnu.2019.02.034 - DOI - PubMed
-
- Oudemans-van Straaten HM, Ostermann M (2012) Bench-to-bedside review: citrate for continuous renal replacement therapy, from science to practice. Crit Care 16:249. https://doi.org/10.1186/cc11645 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical